State Street’s Eledon Pharmaceuticals ELDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.64M | Buy |
605,340
+392,239
| +184% | +$1.06M | ﹤0.01% | 3365 |
|
|
2025
Q1 | $722K | Buy |
213,101
+26,100
| +14% | +$88.5K | ﹤0.01% | 3508 |
|
|
2024
Q4 | $770K | Buy |
187,001
+25,509
| +16% | +$105K | ﹤0.01% | 3539 |
|
|
2024
Q3 | $402K | Hold |
161,492
| – | – | ﹤0.01% | 3639 |
|
|
2024
Q2 | $426K | Buy |
161,492
+116,800
| +261% | +$308K | ﹤0.01% | 3592 |
|
|
2024
Q1 | $92.1K | Hold |
44,692
| – | – | ﹤0.01% | 4044 |
|
|
2023
Q4 | $80.4K | Hold |
44,692
| – | – | ﹤0.01% | 4098 |
|
|
2023
Q3 | $61.2K | Hold |
44,692
| – | – | ﹤0.01% | 4235 |
|
|
2023
Q2 | $61.2K | Hold |
44,692
| – | – | ﹤0.01% | 4370 |
|
|
2023
Q1 | $105K | Hold |
44,692
| – | – | ﹤0.01% | 4308 |
|
|
2022
Q4 | $104K | Hold |
44,692
| – | – | ﹤0.01% | 4359 |
|
|
2022
Q3 | $123K | Hold |
44,692
| – | – | ﹤0.01% | 4383 |
|
|
2022
Q2 | $109K | Hold |
44,692
| – | – | ﹤0.01% | 4491 |
|
|
2022
Q1 | $176K | Buy |
44,692
+4,257
| +11% | +$16.8K | ﹤0.01% | 4429 |
|
|
2021
Q4 | $178K | Hold |
40,435
| – | – | ﹤0.01% | 4396 |
|
|
2021
Q3 | $250K | Buy |
40,435
+7,500
| +23% | +$46.4K | ﹤0.01% | 4276 |
|
|
2021
Q2 | $261K | Buy |
+32,935
| New | +$261K | ﹤0.01% | 4116 |
|
|
2017
Q2 | – | Sell |
-846
| Closed | -$115K | – | 3711 |
|
|
2017
Q1 | $115K | Sell |
846
-8
| -0.9% | -$1.09K | ﹤0.01% | 3535 |
|
|
2016
Q4 | $136K | Buy |
854
+358
| +72% | +$57K | ﹤0.01% | 3518 |
|
|
2016
Q3 | $122K | Buy |
496
+5
| +1% | +$1.23K | ﹤0.01% | 3436 |
|
|
2016
Q2 | $439K | Sell |
491
-45
| -8% | -$40.2K | ﹤0.01% | 3406 |
|
|
2016
Q1 | $487K | Buy |
536
+37
| +7% | +$33.6K | ﹤0.01% | 3356 |
|
|
2015
Q4 | $706K | Buy |
499
+58
| +13% | +$82.1K | ﹤0.01% | 3284 |
|
|
2015
Q3 | $739K | Buy |
441
+93
| +27% | +$156K | ﹤0.01% | 3267 |
|
|
2015
Q2 | $751K | Buy |
348
+68
| +24% | +$147K | ﹤0.01% | 3303 |
|
|
2015
Q1 | $512K | Buy |
280
+105
| +60% | +$192K | ﹤0.01% | 3365 |
|
|
2014
Q4 | $417K | Buy |
+175
| New | +$417K | ﹤0.01% | 3419 |
|